Annual Non Current Assets
$3.89 B
+$261.90 M+7.23%
31 December 2023
Summary:
BioMarin Pharmaceutical annual long term assets is currently $3.89 billion, with the most recent change of +$261.90 million (+7.23%) on 31 December 2023. During the last 3 years, it has risen by +$379.71 million (+10.83%). BMRN annual non current assets is now at all-time high.BMRN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$3.79 B
-$12.89 M-0.34%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly long term assets is currently $3.79 billion, with the most recent change of -$12.89 million (-0.34%) on 30 September 2024. Over the past year, it has dropped by -$8.25 million (-0.22%). BMRN quarterly non current assets is now -3.25% below its all-time high of $3.92 billion, reached on 31 March 2021.BMRN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.2% | -0.2% |
| 3 y3 years | +10.8% | +3.5% |
| 5 y5 years | +63.9% | +40.6% |
BMRN Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +10.8% | -2.4% | +6.0% |
| 5 y | 5 years | at high | +63.9% | -3.3% | +45.6% |
| alltime | all time | at high | >+9999.0% | -3.3% | >+9999.0% |
BioMarin Pharmaceutical Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.79 B(-0.3%) |
| June 2024 | - | $3.81 B(-2.1%) |
| Mar 2024 | - | $3.89 B(+0.1%) |
| Dec 2023 | $2.96 B(+7.4%) | $3.89 B(+2.2%) |
| Sept 2023 | - | $3.80 B(+5.3%) |
| June 2023 | - | $3.61 B(+0.6%) |
| Mar 2023 | - | $3.59 B(-0.9%) |
| Dec 2022 | $2.75 B(+21.0%) | $3.62 B(+1.2%) |
| Sept 2022 | - | $3.58 B(-1.3%) |
| June 2022 | - | $3.63 B(-1.1%) |
| Mar 2022 | - | $3.67 B(-1.7%) |
| Dec 2021 | $2.27 B(-2.9%) | $3.73 B(+1.8%) |
| Sept 2021 | - | $3.67 B(+3.5%) |
| June 2021 | - | $3.54 B(-9.7%) |
| Mar 2021 | - | $3.92 B(+11.9%) |
| Dec 2020 | $2.34 B(+20.6%) | $3.51 B(+2.5%) |
| Sept 2020 | - | $3.42 B(+28.8%) |
| June 2020 | - | $2.65 B(+1.8%) |
| Mar 2020 | - | $2.61 B(-5.1%) |
| Dec 2019 | $1.94 B(-5.5%) | $2.75 B(+1.8%) |
| Sept 2019 | - | $2.70 B(+4.3%) |
| June 2019 | - | $2.59 B(+2.7%) |
| Mar 2019 | - | $2.52 B(+6.2%) |
| Dec 2018 | $2.06 B(-6.8%) | $2.37 B(+3.7%) |
| Sept 2018 | - | $2.29 B(-2.4%) |
| June 2018 | - | $2.34 B(-0.5%) |
| Mar 2018 | - | $2.36 B(-2.9%) |
| Dec 2017 | $2.21 B(+55.2%) | $2.43 B(-4.1%) |
| Sept 2017 | - | $2.53 B(-1.2%) |
| June 2017 | - | $2.56 B(-1.0%) |
| Mar 2017 | - | $2.59 B(-0.6%) |
| Dec 2016 | $1.42 B(+30.5%) | $2.60 B(+19.6%) |
| Sept 2016 | - | $2.18 B(+9.8%) |
| June 2016 | - | $1.98 B(-25.9%) |
| Mar 2016 | - | $2.67 B(+1.3%) |
| Dec 2015 | $1.09 B(-22.0%) | $2.64 B(+7.8%) |
| Sept 2015 | - | $2.45 B(+0.6%) |
| June 2015 | - | $2.43 B(+14.0%) |
| Mar 2015 | - | $2.14 B(+98.2%) |
| Dec 2014 | $1.40 B(+22.9%) | $1.08 B(-20.9%) |
| Sept 2014 | - | $1.36 B(+21.1%) |
| June 2014 | - | $1.13 B(+2.8%) |
| Mar 2014 | - | $1.09 B(-1.1%) |
| Dec 2013 | $1.14 B(+53.0%) | $1.11 B(+22.0%) |
| Sept 2013 | - | $907.05 M(+3.0%) |
| June 2013 | - | $880.60 M(+0.6%) |
| Mar 2013 | - | $875.27 M(+6.1%) |
| Dec 2012 | $743.43 M(+58.2%) | $824.92 M(-2.7%) |
| Sept 2012 | - | $847.99 M(-0.4%) |
| June 2012 | - | $850.99 M(+8.6%) |
| Mar 2012 | - | $783.70 M(-6.2%) |
| Dec 2011 | $469.80 M | $835.91 M(+3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $808.05 M(+5.5%) |
| June 2011 | - | $766.28 M(+0.8%) |
| Mar 2011 | - | $760.32 M(+0.3%) |
| Dec 2010 | $504.26 M(+7.8%) | $758.36 M(+9.9%) |
| Sept 2010 | - | $690.34 M(+48.9%) |
| June 2010 | - | $463.61 M(-0.5%) |
| Mar 2010 | - | $465.77 M(+3.6%) |
| Dec 2009 | $467.73 M(-36.6%) | $449.44 M(+28.7%) |
| Sept 2009 | - | $349.09 M(+3.4%) |
| June 2009 | - | $337.46 M(+80.7%) |
| Mar 2009 | - | $186.71 M(+10.5%) |
| Dec 2008 | $737.70 M(+14.5%) | $169.00 M(+4.3%) |
| Sept 2008 | - | $162.03 M(+6.1%) |
| June 2008 | - | $152.74 M(+6.1%) |
| Mar 2008 | - | $143.97 M(-15.8%) |
| Dec 2007 | $644.30 M(+92.8%) | $170.98 M(+14.1%) |
| Sept 2007 | - | $149.82 M(+6.5%) |
| June 2007 | - | $140.71 M(+9.0%) |
| Mar 2007 | - | $129.12 M(-0.1%) |
| Dec 2006 | $334.22 M(+384.8%) | $129.21 M(+1.2%) |
| Sept 2006 | - | $127.71 M(+3.1%) |
| June 2006 | - | $123.91 M(+13.2%) |
| Mar 2006 | - | $109.47 M(-13.4%) |
| Dec 2005 | $68.94 M(-19.0%) | $126.36 M(-0.2%) |
| Sept 2005 | - | $126.65 M(-1.0%) |
| June 2005 | - | $127.91 M(+0.5%) |
| Mar 2005 | - | $127.33 M(-13.9%) |
| Dec 2004 | $85.16 M(-62.2%) | $147.81 M(-13.8%) |
| Sept 2004 | - | $171.54 M(+3.4%) |
| June 2004 | - | $165.83 M(+444.2%) |
| Mar 2004 | - | $30.47 M(-1.9%) |
| Dec 2003 | $225.27 M(+177.9%) | $31.07 M(+2.7%) |
| Sept 2003 | - | $30.24 M(-3.5%) |
| June 2003 | - | $31.33 M(+10.6%) |
| Mar 2003 | - | $28.32 M(-4.1%) |
| Dec 2002 | $81.07 M(-40.7%) | $29.54 M(-18.2%) |
| Sept 2002 | - | $36.10 M(-0.9%) |
| June 2002 | - | $36.42 M(+7.5%) |
| Mar 2002 | - | $33.88 M(-3.3%) |
| Dec 2001 | $136.78 M(+207.1%) | $35.03 M(-11.9%) |
| Sept 2001 | - | $39.76 M(+14.5%) |
| June 2001 | - | $34.73 M(+17.4%) |
| Mar 2001 | - | $29.58 M(-8.7%) |
| Dec 2000 | $44.54 M(-32.9%) | $32.39 M(+1.5%) |
| Sept 2000 | - | $31.91 M(-2.0%) |
| June 2000 | - | $32.56 M(-1.2%) |
| Mar 2000 | - | $32.94 M(-11.3%) |
| Dec 1999 | $66.42 M(+418.9%) | $37.13 M(+2.8%) |
| Sept 1999 | - | $36.10 M(+19.1%) |
| June 1999 | - | $30.30 M(+42.3%) |
| Mar 1999 | - | $21.30 M |
| Dec 1998 | $12.80 M | - |
FAQ
- What is BioMarin Pharmaceutical annual long term assets?
- What is the all time high annual non current assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual non current assets year-on-year change?
- What is BioMarin Pharmaceutical quarterly long term assets?
- What is the all time high quarterly non current assets for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly non current assets year-on-year change?
What is BioMarin Pharmaceutical annual long term assets?
The current annual non current assets of BMRN is $3.89 B
What is the all time high annual non current assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual long term assets is $3.89 B
What is BioMarin Pharmaceutical annual non current assets year-on-year change?
Over the past year, BMRN annual long term assets has changed by +$261.90 M (+7.23%)
What is BioMarin Pharmaceutical quarterly long term assets?
The current quarterly non current assets of BMRN is $3.79 B
What is the all time high quarterly non current assets for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly long term assets is $3.92 B
What is BioMarin Pharmaceutical quarterly non current assets year-on-year change?
Over the past year, BMRN quarterly long term assets has changed by -$8.25 M (-0.22%)